Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zinc hyaluronate is a small molecule drug that combines the wound-healing and hydrating properties of hyaluronic acid with the antimicrobial and anti-inflammatory effects of zinc. It is primarily used topically for wound care, including the treatment of wounds, burns, acne vulgaris, and to promote skin regeneration. The compound forms a hydrated molecular network on application that acts as an elastoviscous filter—serving as both a mechanical barrier against microorganisms and an antioxidant shield by scavenging reactive oxygen species. This dual action helps maintain moisture at the wound site, reduces inflammation, supports tissue repair, and may reduce scarring. Zinc hyaluronate has been approved for use in several countries under brand names such as Curiosin[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zinc hyaluronate.